July 23rd 2025
Apnimed's first-in-class anti-apneic AD109 increases upper airway muscle tone during sleep; the company plans to file an NDA with the FDA in early 2026.
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers
View More
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
View More
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...
September 6, 2025
Register Now!
What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….
View More
Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies
View More
Community Practice Connections™: 25th Annual International Lung Cancer Congress
View More
Community Practice Connections™: 8th Annual School of Nursing Oncology™
View More
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies
View More
Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L
View More
Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC
View More
Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC
View More
2nd Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
23rd Annual Winter Lung Cancer Conference®
January 23-25, 2026
Register Now!
Future Directions in Treating SCLC and LCNEC-L: The Impact of DLL3
View More
Burst CME™: The Role of HER2 in NSCLC and Implications for Emerging Treatment Strategies
View More
42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow
View More
Community Practice Connections™: 19th Annual New York Lung Cancers Symposium®
View More
A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One
View More
Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients
View More
3rd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference
View More
Influenza: A Tale of Birds, Pigs, and Pandemics
May 13th 2009If Shakespeare were alive, he would urge caution regarding the “Ides of Influenza.” Recent publicity about global influenza, a result of both potential and real avian and swine flu epidemics, has led to a plethora of theories as well as alarm.
Herniation of a Lung Bulla Through a Thoracostomy Site
May 9th 2009For 3 months, a 63-year-old man had experienced progressively worsening dyspnea. He denied fever, weight loss, and hemoptysis. Eight months earlier, he had had a right thoracotomy to drain a right empyema. Comorbidities included morbid obesity, type 2 diabetes mellitus, hypertension, and obstructive sleep apnea. However, he did not have any intrinsic lung disease.
Woman With Recent Respiratory Tract Infection and Anemia
April 1st 2009A 50-year-old woman presents to the emergency department with severe dizziness, weakness, and dyspnea of 1 week’s duration. Ten days earlier, an upper respiratory tract infection (URTI) was diagnosed; over-the-counter cough syrup and acetaminophen were prescribed. However, the patient’s condition has steadily deteriorated since then. In addition, her urine has darkened over the past few days.
Serratia marcescens Pneumonia in an HIV-Infected Patient
August 2nd 2008For 3 days, a 45-year-old woman with HIV infection who was noncompliant with her antiretroviral medications had cough, yellowish sputum, fever, and dyspnea. She denied hemoptysis, weight loss, or recent hospitalization. She had a long history of heavy smoking and alcohol and intravenous drug abuse.
Latest Guidelines on Community-Acquired Pneumonia: Part 2, Empirical Therapy
February 1st 2008New guidelines for community-acquired pneumonia (CAP) issued jointly by the Infectious Diseases Society of America and the American Thoracic Society emphasize the need for communities to adapt the recommendations to local conditions.
Chronic Cough: Seeking the Cause and the Solution
February 1st 2008In the vast majority of nonsmokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination.
What is really causing this woman's asthma exacerbation?
September 1st 2007A 43-year-old woman presented to the emergency department with complaints of severe dyspnea, wheezing, and cough productive of white sputum. She had received a diagnosis of asthma 3 years earlier, based on symptoms of wheezing and cough. Since then, her drug regimen has included intermittent use of albuterol.
What caused an elevated diaphragm in this woman with cough and dyspnea?
A 52-year-old woman presented to her primary care physician complaining of a nonproductive cough and dyspnea on exertion. These symptoms had a subacute onset over 4 weeks before her initial visit. She denied fever, sputum production, hemoptysis, chest pain, palpitations, abdominal pain, nausea, vomiting, and diarrhea. She did not have any known sick contacts.